Related by context. Frequent words. (Click for all words.) 76 double blind placebo 76 blind randomized placebo 75 blind randomized 75 placebo controlled 74 randomized double 74 randomized placebo controlled 72 randomized controlled 68 multicenter 66 prospective randomized 66 randomized 65 dose escalation study 64 randomized clinical 64 safety tolerability 62 multicenter study 62 randomized controlled trial 61 pivotal Phase III 61 pharmacodynamics 60 Phase 2b study 60 prospective cohort 60 Phase 2b clinical 59 tolerability 59 Phase IIb trial 59 pharmacokinetics 59 Phase 2a clinical 59 Phase 1b 59 pivotal Phase 58 Phase Ib 58 Phase III clinical 57 dose escalation 57 Phase IIa clinical 57 Phase IIb 57 multiple ascending dose 57 Phase III clinical trials 57 Phase 2b trial 57 clinical trial 56 Phase IIa 56 Phase IIa trial 56 mg BID 55 Phase 2b 55 Phase IIb clinical 54 randomized Phase 54 mg dose 54 non inferiority 54 randomized controlled trials 54 relapsing remitting multiple sclerosis 54 dose regimen 54 Phase III pivotal 53 randomized clinical trials 53 Phase III 53 monotherapy 52 Phase 2a 52 pharmacokinetic 52 lubiprostone 52 RG# [001] 52 plus ribavirin 52 evaluable patients 52 investigational drug 52 primary endpoint 52 TMC# [001] 51 randomized trials 51 pegylated interferon 51 PRX # 51 rosuvastatin 51 Phase III trials 51 observational study 51 ACTEMRA 51 SEROQUEL 50 eculizumab 50 pharmacokinetic profile 50 etanercept 50 pharmacodynamic 50 dosing regimens 50 relapsing remitting MS 50 mg/m2 50 mg doses 50 dose limiting toxicities 50 CYPHER R Stent 49 postmenopausal women 49 CK # 49 immunogenicity 49 REBETOL 49 evaluable 49 mcg 49 PEGINTRON 49 Clinical Study 48 n = 48 LEVADEX 48 Zerenex 48 capecitabine 48 investigational compound 48 FOLFOX 48 placebo 48 JANUVIA 48 CYT# 48 secondary endpoint 48 primary efficacy endpoint 48 orally administered 48 antiviral activity 48 citalopram 48 longitudinal study 48 temozolomide